Different Modes of Cell-killing Action between DNA Topoisomerase I and II Inhibitors Revealed by Kinetic Analysis
Open Access
- 1 February 1994
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 85 (2), 187-193
- https://doi.org/10.1111/j.1349-7006.1994.tb02081.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- UCE6, A new antitumor antibiotic with topoisomerase I mediated DNA cleavage activity, from actinomycetes.The Journal of Antibiotics, 1993
- Induction of mammalian DNA topoisomerase I mediated DNA cleavage by antitumor indolocarbazole derivativesBiochemistry, 1992
- Does bulk damage to DNA explain the cytostatic and cytotoxic effects of topoisomerase II inhibitors?Biochemical Pharmacology, 1991
- Cell death induced by topoisomerase inhibitors: Role of calcium in mammalian cellsBiochemical Pharmacology, 1991
- Kinetic Analysis of 5‐Fluorouracil Action against Various Cancer CellsJapanese Journal of Cancer Research, 1990
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- Inhibition of protein synthesis reduces the cytotoxicity of 4'-(9-acridinylamino) methane-sulfon-m-anisidide without affecting DNA breakage and DNA topoisomerase ii in a murine mastocytoma cell lineBiochemical Pharmacology, 1989
- Cell killing action of cell cycle phase-non-specific antitumor agents is dependent on concentration-time productCancer Chemotherapy and Pharmacology, 1988
- Abrogation of etoposide-mediated cytotoxicity by cycloheximideBiochemical Pharmacology, 1988
- Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle.Proceedings of the National Academy of Sciences of the United States of America, 1988